Pricing and Contracting

Discount Safe Harbor Proposed Rule: How Process Works and What does it mean?

SAFE HARBOR PROPOSED RULE PROCESS The Discount Safe Harbor Proposed Rule was issued by the Department of Health and Human Services (HHS) earlier this year, and over 25,000 comments have…

Read Full Article

Contract Lifecycle Management (CLM) in Life Sciences – A Strong Uptake

Contract Lifecycle Management (CLM) implementations are picking up, replacing legacy systems with cloud-based technologies. Besides the benefits of a CLM tool as shown in the diagram below, there are a…

Read Full Article

Contract Lifecycle Management (CLM) in Life Sciences – A Strong Uptake

Contract Lifecycle Management (CLM) implementations are picking up, replacing legacy systems with cloud-based technologies. Besides the benefits of a CLM tool as shown in the diagram below, there are a…

Read Full Article

CMS 2019 Final Rule and the Scope of the 340B Program

In its final rule for 2018, the Centers for Medicare and Medicaid Services (CMS) reduced Medicare Part B reimbursement for 340B-acquired drugs from Average Sales Price (ASP) plus 6% to…

Read Full Article

Refining Cost Sharing: Barriers to Outcome-Based Agreements in the U.S.

WHAT ARE OUTCOMES-BASED AGREEMENTS (OBA)? Currently, market forces, including volume, competition, and Research & Development expenditures, determine the prices for pharmaceutical therapies in the U.S. market. However, as prices for…

Read Full Article

Switch Operator – Current Role and Potential Impacts

Co-written by Catherine Trentini, Senior Consultant, Pricing, Contracting & Market Access As the healthcare industry is in a state of rapid change, the pharmaceutical supply chain and how consumers receive…

Read Full Article

Medicare Part D Bids and Discount Safe Harbor Timeline

For those whose only association with Medicare comes from being a participant in a health insurance plan, chances are individuals are not aware of the extensive path each plan takes…

Read Full Article

Diverging before Converging; SPC Waiver and its effect on European Healthcare and Pharma

Co-authored by Todor Finkov, Manager, Pricing, Tenders & Contracts In 2015, the European Union (EU) set a single market strategy that provided more opportunities to people and business.[i] It enables people, services, goods…

Read Full Article

Purchase-based Contracting Operational Considerations within Specialty Pharma

Since the infancy of specialty drugs on the market in the 1990s, specialty pharmaceuticals have attracted attention in part due to the complex supply chain and high-touch requirements before, during…

Read Full Article